Formulations for PK/Efficacy/Tox Studies
  • Reads 2
  • Votes 0
  • Parts 1
  • Time <5 mins
  • Reads 2
  • Votes 0
  • Parts 1
  • Time <5 mins
Ongoing, First published Apr 08, 2024
https://www.crystalpharmatech.com/preclinical-formulation-development/


Preclinical Formulation for PK/Efficacy/Tox Studies
Contrary to popular belief, early preclinical formulation development is not simply dumping API in a vehicle and gavage feeding an animal. If you do this, you will most likely lose time and money with unnecessary and confusing PK studies. This led to the development of our SMART biopharmaceutical solutions that offer input from our scientific advisory board: A one-stop shop from candidate selection through GMP FIH.
All Rights Reserved
Sign up to add Formulations for PK/Efficacy/Tox Studies to your library and receive updates
or
#11formulation
Content Guidelines
You may also like
Slide 1 of 1
Brittanie's Writer Room cover

Brittanie's Writer Room

15 parts Ongoing

A place for all things Brittanie!